Today Sonnet (NASDAQ: SONN) quickly soars above 70% on increasing 100 million shares along with Tiziana (TLSA) and ElectroCore (ECOR) who announce valuable news to investors.
July has brought not much change for SONN except this day while stock futures surge slowly. Biotech stocks are rising now steeply together with tech stocks like Pinterest (PINS), Jumia (JMIA), and Facebook (FB) due to speculative news around the COVID-19 vaccine.
Sonnet has no earnings yet because of low revenue caused by insufficient product range. The stock is still penny giving a viable opportunity to gambling investors who believe in ‘good risk’. Losing small cash will bring no serious consequences to the portfolio.